Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $745.9900 (0.32%) ($745.9900 - $745.9900) on Fri. Jul. 28, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.74% (three month average) | RSI | 78 | Latest Price | $745.9900(0.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.3% a day on average for past five trading days. | Weekly Trend | REGN advances 1.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(50%) XLV(50%) DIA(36%) XLF(36%) IVW(35%) | Factors Impacting REGN price | REGN will decline at least -0.87% in a week (0% probabilities). VXX(-37%) VIXM(-35%) EDOC(-19%) GLD(-8%) USO(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.87% (StdDev 1.74%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $735.21(1.47%) | 10 Day Moving Average | $730.64(2.1%) | 20 Day Moving Average | $722.04(3.32%) | To recent high | -7.5% | To recent low | 7.8% | Market Cap | $79.096b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |